AI-generated summary
The authors treated 14 men with facial actinic keratoses using 1550-nm fractional erbium-doped fiber laser sessions over several weeks and tracked lesion counts for six months. Lesion counts fell on average by 73.1% at one month, 66.2% at three months, and 55.6% at six months, but follow-up biopsies still showed histologic features of actinic keratosis and/or squamous cell carcinoma, so the authors conclude the treatment is not an adequate single modality.
- Participants
- 14
- Who or what was studied
- 14 men aged 59 to 79 years with facial actinic keratoses
- Wavelengths
- 1550 nm
- Limits stated in the abstract
- The authors state the study is limited by a small number of patients and that further clinical studies are warranted.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.